Patient Advocacy, Pandemic Impact

Amy Blum of the National Gaucher Foundation discusses the important role patient advocacy groups can play in helping the rare disease community during the current COVID-19 pandemic.

This presentation was part of the live GRIDS 2020-Virtual Summit held July 1, 2020 and is now available exclusively on CheckRare.

To receive CME credit for sessions from the summit, go to checkrare.com/learning/p-grids2020-module4-lysosomal-disease-management-and-covid-19/